These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
828 related articles for article (PubMed ID: 15998892)
1. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. Thompson IM; Ankerst DP; Chi C; Lucia MS; Goodman PJ; Crowley JJ; Parnes HL; Coltman CA JAMA; 2005 Jul; 294(1):66-70. PubMed ID: 15998892 [TBL] [Abstract][Full Text] [Related]
2. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. Thompson IM; Chi C; Ankerst DP; Goodman PJ; Tangen CM; Lippman SM; Lucia MS; Parnes HL; Coltman CA J Natl Cancer Inst; 2006 Aug; 98(16):1128-33. PubMed ID: 16912265 [TBL] [Abstract][Full Text] [Related]
3. Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter. Horninger W; Cheli CD; Babaian RJ; Fritsche HA; Lepor H; Taneja SS; Childs S; Stamey TA; Sokoll LJ; Chan DW; Brawer MK; Partin AW; Bartsch G Urology; 2002 Oct; 60(4 Suppl 1):31-5. PubMed ID: 12384160 [TBL] [Abstract][Full Text] [Related]
4. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM N Engl J Med; 2003 Jul; 349(4):335-42. PubMed ID: 12878740 [TBL] [Abstract][Full Text] [Related]
5. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower. Walz J; Haese A; Scattoni V; Steuber T; Chun FK; Briganti A; Montorsi F; Graefen M; Huland H; Karakiewicz PI Cancer; 2008 Nov; 113(10):2695-703. PubMed ID: 18853417 [TBL] [Abstract][Full Text] [Related]
6. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men. Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study. Marberger M; Freedland SJ; Andriole GL; Emberton M; Pettaway C; Montorsi F; Teloken C; Rittmaster RS; Somerville MC; Castro R BJU Int; 2012 Apr; 109(8):1162-9. PubMed ID: 21699645 [TBL] [Abstract][Full Text] [Related]
8. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Parnes HL; Lippman SM; Coltman CA J Urol; 2007 May; 177(5):1749-52. PubMed ID: 17437804 [TBL] [Abstract][Full Text] [Related]
9. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range. Haese A; Dworschack RT; Partin AW J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. Thompson IM; Pauler DK; Goodman PJ; Tangen CM; Lucia MS; Parnes HL; Minasian LM; Ford LG; Lippman SM; Crawford ED; Crowley JJ; Coltman CA N Engl J Med; 2004 May; 350(22):2239-46. PubMed ID: 15163773 [TBL] [Abstract][Full Text] [Related]
11. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death. Hattangadi JA; Chen MH; D'Amico AV BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests. Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069 [TBL] [Abstract][Full Text] [Related]
13. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution. Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809 [TBL] [Abstract][Full Text] [Related]
14. The cutoff level of free/total prostate specific antigen (f/t PSA) ratios in the diagnosis of prostate cancer: a validation study on a Turkish patient population in different age categories. Erol B; Gulpinar MT; Bozdogan G; Ozkanli S; Onem K; Mungan G; Bektas S; Tokgoz H; Akduman B; Mungan A Kaohsiung J Med Sci; 2014 Nov; 30(11):545-50. PubMed ID: 25458043 [TBL] [Abstract][Full Text] [Related]
15. Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer. Carter HB; Epstein JI; Chan DW; Fozard JL; Pearson JD JAMA; 1997 May; 277(18):1456-60. PubMed ID: 9145718 [TBL] [Abstract][Full Text] [Related]
16. PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience. Ramos CG; Valdevenito R; Vergara I; Anabalon P; Sanchez C; Fulla J Urol Oncol; 2013 Nov; 31(8):1522-6. PubMed ID: 22687565 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer. Ito K; Yamamoto T; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H Urology; 2000 Aug; 56(2):278-82. PubMed ID: 10925094 [TBL] [Abstract][Full Text] [Related]
18. Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination. Chiu PK; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF Investig Clin Urol; 2016 Sep; 57(5):336-42. PubMed ID: 27617315 [TBL] [Abstract][Full Text] [Related]
19. Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL. Kobayashi T; Mitsumori K; Kawahara T; Nishizawa K; Ogura K; Ide Y Int J Urol; 2005 Nov; 12(11):969-75. PubMed ID: 16351653 [TBL] [Abstract][Full Text] [Related]
20. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. Catalona WJ; Richie JP; deKernion JB; Ahmann FR; Ratliff TL; Dalkin BL; Kavoussi LR; MacFarlane MT; Southwick PC J Urol; 1994 Dec; 152(6 Pt 1):2031-6. PubMed ID: 7525994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]